Acadia Pharmaceuticals Inc. logo

Acadia Pharmaceuticals Inc. (DR6)

Market Closed
2 Jun, 06:06
18. 73
-0.8
-4.12%
- Market Cap
- P/E Ratio
0% Div Yield
0 Volume
-0.34 Eps
19.54
Previous Close
Day Range
18.73 18.73
Year Range
12.29 19.7
Earnings results expected in 61 days
Want to track DR6 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Acadia Pharmaceuticals Inc. logo
DR6 Acadia Pharmaceuticals Inc.
4 Aug 2025 (61 Days)
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
DR6 Acadia Pharmaceuticals Inc.
7 May 2025
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
DR6 Acadia Pharmaceuticals Inc.
6 May 2025
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
DR6 Acadia Pharmaceuticals Inc.
25 Feb 2025
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
DR6 Acadia Pharmaceuticals Inc.
6 Nov 2024
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
DR6 Acadia Pharmaceuticals Inc.
31 Oct 2024
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
DR6 Acadia Pharmaceuticals Inc.
6 Aug 2024
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
DR6 Acadia Pharmaceuticals Inc.
31 Jul 2024
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
DR6 Acadia Pharmaceuticals Inc.
29 May 2024
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
DR6 Acadia Pharmaceuticals Inc.
8 May 2024
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
DR6 Acadia Pharmaceuticals Inc.
27 Feb 2024
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
DR6 Acadia Pharmaceuticals Inc.
2 Nov 2023
-
Cons. EPS
-
EPS